NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹283.71 | ₹202.74 | ₹233.89 | ₹127.45 | ₹49.74 |
What is the latest Earnings Per Share (EPS) of NEULAND LABORATORIES ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹283.71 |
| Mar2025 | ₹202.74 |
| Mar2024 | ₹233.89 |
| Mar2023 | ₹127.45 |
| Mar2022 | ₹49.74 |
How is Earnings Per Share (EPS) of NEULAND LABORATORIES Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹283.71 | 39.94 | |
| Mar2025 | ₹202.74 | -13.32 | |
| Mar2024 | ₹233.89 | 83.52 | |
| Mar2023 | ₹127.45 | 156.23 | |
| Mar2022 | ₹49.74 | - | |
Compare Earnings Per Share (EPS) of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹25,554.8 Cr | 3.9% | 5.6% | 39.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -2.6% | 2.4% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹221,666.0 Cr | 6.5% | 23.3% | 25.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,108.0 Cr | 2.6% | 3% | 33.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.1% | -0.2% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,990.9 Cr | 2.6% | -13.3% | -10.7% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 3.9% |
5.6% |
39.3% |
| SENSEX | 1.2% |
0.4% |
-2.9% |
You may also like the below Video Courses